154 related articles for article (PubMed ID: 2852792)
21. Evaluation of a reassortant rhesus rotavirus vaccine in young children.
Tajima T; Thompson J; Wright PF; Kondo Y; Tollefson SJ; King J; Kapikian AZ
Vaccine; 1990 Feb; 8(1):70-4. PubMed ID: 2156387
[TBL] [Abstract][Full Text] [Related]
22. A trial of RIT-4237 rotavirus vaccine in 1-month-old infants.
Mutz ID; Krainer F; Deutsch J; Kunz C; Teuwen DE
Eur J Pediatr; 1989 Jun; 148(7):634-5. PubMed ID: 2545451
[TBL] [Abstract][Full Text] [Related]
23. Protective efficacy against serotype 1 rotavirus diarrhea by live oral rhesus-human reassortant rotavirus vaccines with human rotavirus VP7 serotype 1 or 2 specificity.
Vesikari T; Ruuska T; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1992 Jul; 11(7):535-42. PubMed ID: 1326741
[TBL] [Abstract][Full Text] [Related]
24. Reactogenicity and antigenicity of the rhesus rotavirus vaccine in Venezuelan children.
Perez-Schael I; Gonzalez M; Daoud N; Perez M; Soto I; Garcia D; Daoud G; Kapikian AZ; Flores J
J Infect Dis; 1987 Feb; 155(2):334-8. PubMed ID: 3027196
[No Abstract] [Full Text] [Related]
25. Tetravalent rhesus rotavirus vaccine in young infants.
Kobayashi M; Thompson J; Tollefson SJ; Reed GW; Wright PF
J Infect Dis; 1994 Nov; 170(5):1260-3. PubMed ID: 7963722
[TBL] [Abstract][Full Text] [Related]
26. Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine.
Vesikari T; Isolauri E; D'Hondt E; Delem A; André FE; Zissis G
Lancet; 1984 May; 1(8384):977-81. PubMed ID: 6143964
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of rhesus rotavirus vaccine (MMU 18006) in infants and young children.
Anderson EL; Belshe RB; Bartram J; Crookshanks-Newman F; Chanock RM; Kapikian AZ
J Infect Dis; 1986 May; 153(5):823-31. PubMed ID: 3009633
[TBL] [Abstract][Full Text] [Related]
28. Field trial of rhesus rotavirus or human-rhesus rotavirus reassortant vaccine of VP7 serotype 3 or 1 specificity in infants. The Elmwood, Panorama, and Westfall Pediatric Groups.
Madore HP; Christy C; Pichichero M; Long C; Pincus P; Vosefsky D; Kapikian AZ; Dolin R
J Infect Dis; 1992 Aug; 166(2):235-43. PubMed ID: 1321858
[TBL] [Abstract][Full Text] [Related]
29. Neonatal rotavirus vaccination with RIT 4237 bovine rotavirus vaccine: a preliminary report.
Vesikari T; Ruuska T; Delem A; André FE
Pediatr Infect Dis J; 1987 Feb; 6(2):164-9. PubMed ID: 3031574
[TBL] [Abstract][Full Text] [Related]
30. Safety, infectivity, transmissibility and immunogenicity of rhesus rotavirus vaccine (MMU 18006) in infants.
Losonsky GA; Rennels MB; Kapikian AZ; Midthun K; Ferra PJ; Fortier DN; Hoffman KM; Baig A; Levine MM
Pediatr Infect Dis; 1986; 5(1):25-9. PubMed ID: 3003715
[TBL] [Abstract][Full Text] [Related]
31. Symptoms associated with rhesus-human reassortant rotavirus vaccine in infants.
Joensuu J; Koskenniemi E; Vesikari T
Pediatr Infect Dis J; 1998 Apr; 17(4):334-40. PubMed ID: 9576390
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the M37 human rotavirus vaccine in 2- to 6-month-old infants.
Vesikari T; Ruuska T; Koivu HP; Green KY; Flores J; Kapikian AZ
Pediatr Infect Dis J; 1991 Dec; 10(12):912-7. PubMed ID: 1662796
[TBL] [Abstract][Full Text] [Related]
33. Safety and immunogenicity of tetravalent rhesus-based rotavirus vaccine in Bangladesh.
Bresee JS; El Arifeen S; Azim T; Chakraborty J; Mounts AW; Podder G; Gentsch JR; Ward RL; Black R; Glass RI; Yunus M
Pediatr Infect Dis J; 2001 Dec; 20(12):1136-43. PubMed ID: 11740320
[TBL] [Abstract][Full Text] [Related]
34. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial.
Bines JE; Danchin M; Jackson P; Handley A; Watts E; Lee KJ; West A; Cowley D; Chen MY; Barnes GL; Justice F; Buttery JP; Carlin JB; Bishop RF; Taylor B; Kirkwood CD;
Lancet Infect Dis; 2015 Dec; 15(12):1389-97. PubMed ID: 26318715
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period.
Ruuska T; Vesikari T; Delem A; André FE; Beards GM; Flewett TH
Scand J Infect Dis; 1990; 22(3):269-78. PubMed ID: 2164706
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of two doses of RIT 4237 bovine rotavirus vaccine for prevention of rotavirus diarrhoea.
Vesikari T; Ruuska T; Delem A; André FE; Beards GM; Flewett TH
Acta Paediatr Scand; 1991 Feb; 80(2):173-80. PubMed ID: 1852084
[TBL] [Abstract][Full Text] [Related]
37. Neonatal administration of rhesus rotavirus tetravalent vaccine.
Vesikari T; Karvonen A; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
Pediatr Infect Dis J; 2006 Feb; 25(2):118-22. PubMed ID: 16462287
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial.
Bernstein DI; Sack DA; Rothstein E; Reisinger K; Smith VE; O'Sullivan D; Spriggs DR; Ward RL
Lancet; 1999 Jul; 354(9175):287-90. PubMed ID: 10440305
[TBL] [Abstract][Full Text] [Related]
39. Rhesus Rotavirus candidate vaccine. Clinical trial in children vaccinated between 2 and 5 months of age.
Vesikari T; Rautanen T; Varis T; Beards GM; Kapikian AZ
Am J Dis Child; 1990 Mar; 144(3):285-9. PubMed ID: 2154925
[TBL] [Abstract][Full Text] [Related]
40. A comparative trial of rhesus monkey (RRV-1) and bovine (RIT 4237) oral rotavirus vaccines in young children.
Vesikari T; Kapikian AZ; Delem A; Zissis G
J Infect Dis; 1986 May; 153(5):832-9. PubMed ID: 3009634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
